The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
People dumping no revenue
Looks strong
No revenue dumping
Blue
Dr. Dk Ed. Dodgy prognosis again. Lol
Adding more
",they just need not to go bankrupt before it happens."
Amen to that.
I thought that was the whole idea of this company to use dna to identify drugs to save lives,this is going to be one of many such collaborations, a royalty is just that future money in the bank,when a larger company does all the work to get the trials done and fda approved,then millions in revenue,how long it takes is a few yrs if the trials go well, look at genedrive,they have 2 brilliant ideas and hardly any sales as still waiting on nhs and nice approval,if it was easy we would all be doing it,there products work for the deafness and the stroke risk tests dont they,, they are also tryng for fda approval for the stroke test,if they get it they are made,they just need not to go bankrupt before it happens.
Wonder if we will get an interview
What a great start to the day.
Techs and news both pointing to a decent move higher
It’s a project
Future definitely looking very bright. Could see multiples over the next 12 months
You’re nuts - £200k contract with long term milestones and royalties great addition to their portfolio.
No Revenue means a drop in a false rise yesterday.
Wow that’s decent
"and a huge royalty payment when the drug is approved and sold...."
Oldslow, do you have any idea of how many years it takes to get a pre-clinical drug FDA approved?
Youre not really a dr. are you?? dr de'ath perhaps?
Broker note last week and company confirmed cash enough to see out recovery strategy to cash neutrality by fy26 ….Whate your problem Micho
What are you on ? 😂
Another £200k plus, and a huge royalty payment when the drug is approved and sold,money in the bank for at least 25yrs from the patented drugs.
Pump before next placing. Rise was yesterday red today as expected.
Great to see royalty entitlement built in. Fusion CEO at end of November 2020 indicated his view at that stage that potential for £30/40m in milestone payments if all entitlements came off at that stage. This was before they started to build royalt and milestones into their business model. Some real potential for some of those to come in at some stage.
Another one under their belt!
Less than 2 months into the year and they’ve already got 85% of last years revenue into the order book to be recognised this year!
Recovery is very much in play!!
Was a positive write up to be fair
That did more to excite my interest in taking a few than the presentation talk on the investor meet platform, perhaps its his shiny bald head, i don't know. They don't sound enthusiastic do they?
Some positive PR could really help here